Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nerva
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Nerva is a leading, research-backed digital therapeutic for irritable bowel syndrome (IBS), utilizing gut-directed hypnotherapy and cognitive behavioral therapy via a mobile app. Clinical studies and real-world data show significant improvements for the majority of users, comparable to the low FODMAP diet, with >300,000 people treated and strong adherence over a six-week program[1][7][9].
- Therapeutic areas
- Gastroenterology
- Modalities
- Non-pharmacological therapyDevice
- Industry
- Digital Health Medical Devices
Beyond the preview
Go deeper on Nerva.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nerva.